๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
This Phase 1 first-in-human single ascending dose study will be a randomize...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2015-08
Trial ID
NCT02531815
Treatments Being Tested
To Evaluate the Safety, Tolerability and Pharmacokinetics on DA-302168S Tab...
Status
Completed
Location
Gulou Hospital Affiliated to Nanjing Medical University
Start Date
2024-04-18
Trial ID
NCT06534320
Treatments Being Tested
A safety study of KAN-101 in patients with celiac disease. The study has tw...
Status
Completed
Location
Anaheim Clinical Trials
Start Date
2020-01-21
Trial ID
NCT04248855
This is a Phase 1 study to assess the the safety, tolerability and pharmaco...
Status
Completed
Location
Research Site
Start Date
2022-04-04
Trial ID
NCT05351047
Treatments Being Tested
This is a randomized, placebo-controlled, double-blind, 3-way crossover pha...
Status
Completed
Location
Research Site
Start Date
2017-09-06
Trial ID
NCT03258515
Treatments Being Tested
The main purpose of this study is to assess how well LY3971297 is tolerated...
Status
Recruiting
Location
Henry Ford Health System
Start Date
2026-08-11
Trial ID
NCT07547540
This is a the first in human study to evaluate the safety, tolerability, PK...
Status
Completed
Location
Huashan Hospital Affiliated to Fudan University
Start Date
2020-08-27
Trial ID
NCT04511624
Treatments Being Tested
This study is designed to assess tolerability of the weight-adjusted dose o...
Status
Completed
Location
The Lindner Research Center
Start Date
2019-02-18
Trial ID
NCT03844191
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability and pharmac...
Status
Completed
Location
Hammersmith Medicines Research
Start Date
2015-08-26
Trial ID
NCT02561156
Treatments Being Tested
This is a phase Ib, randomized, double-blind, placebo-controlled, multiple ...
Status
Recruiting
Location
The first Affiliated Hospital of Guangxi Medical University
Start Date
2024-12-30
Trial ID
NCT06772766
Treatments Being Tested